All these three companies closed their public issues today, December 10 and will finalise their IPO share allotment by December 11. Their shares will be available for trading on the BSE SME effective December 15.
Jindal Supreme IPO | The company proposed to issue over 1.07 crore fresh shares, while promoter VVJ Enterprise will be selling 26.86 lakh shares via offer-for-sale.
SBI Mutual Fund was established in 1987 with SBI as the sponsor and was the first non-UTI mutual fund in India.
Wakefit IPO share allotment is expected by December 11, while share listing is proposed on December 15.
Nephrocare Health Services IPO GMP: The price band for the IPO has been set at Rs 438-460 per share.
Corona Remedies IPO GMP: Corona Remedies IPO is entirely an offer-for-sale of shares at a price band of Rs 1,008-1,062 apiece.
ICICI Prudential AMC shares will list on the exchanges on December 19, while the allotment is expected by December 17.
Park Medi World is the second-largest private hospital chain in North India with 3,000 beds, and the largest in Haryana with 1,600 beds.
Anand Rathi, has come out with its report on Park Medi World Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 09, 2025.
Anand Rathi, has come out with its report on Nephrocare Health Services Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 09, 2025.
Vidya Wires share market debut was below than the expectations in the grey market, which had expected a 7 percent listing gain.
Aequs share price: This comes after the Rs 922-crore IPO was subscribed nearly 102 times from December 3-5.
Meesho share market debut was better than the expectations in the grey market, which had expected a listing gain of about 39 percent.
India’s IPO pipeline is swelling rapidly, with 88 companies already securing SEBI approval to raise Rs 1.16 lakh crore and another 104 awaiting clearance for nearly Rs 1.4 lakh crore
Two of the country’s prominent investment banks — Arif Habib Ltd. and Ktrade Securities Ltd. — have a combined pipeline of as many as 16 IPOs over the next seven months
The Rs 922-crore IPO had attracted strong investor demand, getting subscribed nearly 102 times during the bidding window from December 3 to 5.
InCred has given the stock a Subscribe rating for near-term gains, citing attractive valuations at 5.3x market cap-to-sales.
Park Medi World IPO | The Rs 920-crore initial public offering will open during December 10-12, with price band of Rs 154-162 per share.
The Nephrocare Health Services IPO is a combination of fresh issuance of shares worth Rs 353.4 crore, and an offer-for-sale of 1.12 crore shares by existing shareholders.
KSH International IPO | The stake sale has done at a price of Rs 384 per share, valuing the company at little more than Rs 2,600 crore.
Steamhouse India IPO | The company proposed to mobilise Rs 345 crore by issuing fresh shares, while promoter Vishal Sanwarprasad Budhia will offload shares worth up to Rs 80 crore via offer-for-sale.
The analysts advised investors to hold the Vidya Wires shares for the medium to long term.
Analysts expect the Meesho shares to list at a 25–30 percent premium and advise a cautious approach thereafter, depending on investor risk appetite.
The SEBI had put the issuance of observations on Sterlite Electric’s IPO papers in abeyance on October 27.
Aequs listing expectations: Analysts advised investors to book partial profits on listing gains and holding the rest for long term.
